期刊文献+

不同分期慢性淋巴细胞白血病患者外周血T-bet、GATA-3、RORγt和Foxp3 mRNA的表达变化 被引量:7

mRNA Expressions of T-bet,GATA-3,ROR γt and Foxp3 in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia in Different Stages
下载PDF
导出
摘要 目的:研究特异性转录因子T-bet、GATA-3、RORγt和Foxp3 mRNA在不同分期慢性淋巴细胞白血病(CLL)患者外周血中的表达情况并探讨其在CLL发病机制中可能的作用及临床意义。方法:选择46例初诊未治疗CLL患者为病例组(其中Binet A期15例,Binet B期16例,Binet C期15例),20名健康人作为对照组,通过荧光实时定量PCR方法分别检测各组外周血单个核细胞(PBMNC)中T-bet、GATA-3、RORγt和Foxp3 mRNA的表达。结果:1 CLL患者外周血中T-bet mRNA表达低于正常对照组(P<0.05),GATA-3、RORγt、Foxp3 mRNA的表达均高于正常对照组(P值均<0.05),T-bet/GATA-3与RORγt/Foxp3比值均低于正常对照组(P值均<0.05);2分期越晚,GATA-3 mRNA和Foxp3 mRNA的表达量越高,其中B期和C期的GATA-3 mRNA表达高于A期(P<0.05),C期的Foxp3 mRNA表达高于A期和B期(P<0.05);分期越晚,T-bet/G ATA-3和RORγt/Foxp3比值越低。其中A期的T-bet/GATA-3比值高于C期(P<0.05),A期与B期的RORγt/Foxp3比值均高于C期(P<0.05)。结论:本研究从转录因子层面发现在CLL患者中,随着病程的进展,Th1/Th2和Th17/Treg平衡分别向Th2和Treg偏移,Treg细胞可能在CLL的发生发展中起着重要的免疫抑制作用。 Objective: This study was to investigate the mRNA expression of T-bet, GATA-3, ROR γt and Foxp3 mRNA in peripheral blood of patients with chronic lymphocytic leukemia ( CLL ) in different stages and explore their potential role in the pathogenesis and clinical diagnosis. Methods: A total of 46 newly diagnosed and untreated patients with CLL was chosen as patient group, including 16 patients in the stage of Binet A, 15 in the stage of Binet B, and 15 in the stage of Binet C; 20 healthy persons were selected as controls. The quantitative fluorescence PCR was adopted to detect the mRNA expression of T-bet, GATA-3, RORTt and Foxp3 in peripheral blood mononuclear cell (PBMNC). Results : ( 1 ) The expression of T-bet mRNA in patient group was lower than that in normal controls( P 〈 0.05 ), while the mRNA expression of GATA-3 mRNA, ROR 7t, Foxp3 in CLL patients group were higher than that in normal controls ( P 〈 0. 05 ), and the ratio of T-bet/GATA-3 and RORγt/Foxp3 in CLL in patient group were lower than that in normal controls(P〈0.05) ; (2) The later the stage, the higher the mRNA expression of GATA-3 and Foxp3. The mRNA expression of GATA-3 in stage Binet B and stage Binet C of CLL patients were higher than that in stage Binet A ( P 〈 0.05 ), and the mRNA expression of Foxp3 in stage Binet C was higher than that in stage of Binet A and Binet B ( P 〈 0. 05 ) ; the later the stage, the lower the ratio of T-bet/GATA-3 and RORγt/Foxp3. The ratio of T-bet/GATA-3 in stage of Binet A CLL patients was higher than that in stage Binet C ( P 〈 0.05 ) and the ratio of RORγt/Foxp3 in stage of Binet A and stage of Binet B were higher than that in stage Binet C ( P 〈 0.05 ). Conclusion: This study found in the level of transcription factors in CLL patients that with the process of disease, the balance shifts from Thl/Th2 and Thl7/Treg to Thl7 and Treg, and Treg cell may play a critical immunosuppressive role in the development of CLL.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第1期45-49,共5页 Journal of Experimental Hematology
基金 新疆维吾尔自治区自然科学基金(2013211A100)
关键词 慢性淋巴细胞白血病 T-BET基因 GATA-3基因 RORγt基因 FOXP3基因 chronic lymphocytic leukemia T-bet gene GATA-3 gene ROR yt gene Foxp3 gene
  • 相关文献

参考文献19

  • 1Chiorazzi N,Rai KR,Ferrarini M.Chronic lymphocytic leukemia.N Engl J Med,2005;352(8):804-815.
  • 2Hojjat-Farsangi M,Jeddi-Tehrani M,Razavi SM,et al.Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.Cancer Sci,2009;100(12):2346-2353.
  • 3Tamura K,Sawada H,Izumi Y,et al.Chronic lymphocytic leukemia(CLL)is rare,but the proportion of T-CLL is high in Japan.European Journal of hematology,2001;67(3):152-157.
  • 4Salluto F,Lanzavecchia A.Heterogeneity of CD4+memory T cells:functional modules for tailored immunity.Eur J Immunnol,2009;39(8):2076-2082.
  • 5Jain P,Javdan M,Feger FK,et al.Thl7 and non-Thl7 interleukin-17-expressing cells in chronic lymphocytic leukemia:delineation,distribution,and clinical relevance.Hematologic,2012;97(4):599-607.
  • 6Szabo SJ,kinv ST,Costa GL,et al.A novel transcription factor,Tbet,directs Th1 lineage commitment cell,2000;100(6):655-669.
  • 7Seki N,Miyazaki M,Suzuki W,et al.IL-4 induced GATA-3 expression is a time-restricted instruction switch for Th2 cell differentiation.J Immunol,2004;172(10):6158-6166.
  • 8Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003;299(5609):1057-1061.
  • 9Podhorecka M,Dmoszynska A,Rolinski J,et al.T type1/type2subsets balance in B-cell chronic lymphocytic leukemia-the three-color flow cytometry analysis.Leuk Res,2002;26(7):657-660.
  • 10Mantovani G,Maccio A,Esu S,et al.Levels of IL-4,IL-10 and INF gamma in the serum and in the PBMC culture supernatants from 31 patients with hematological malignancies.Oxford:Blackwell Scientific Publication,1998;102-118.

二级参考文献15

  • 1D'Arena G, Simeon V, D'Auria F, et al. Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander[ J ] ? Am J Blood Res, 2013, 3(1) : 52 -57.
  • 2Piper KP, Karanth M, McLarnon A, et al. Chronic lymphocytic leukaemia cells drive the global CD4 + T cell repertoire towards a regulatory phenotype and leads to the accumulation of CIM + forkhead box P3 + T cells [ J ]. Clin Exp Immunol, 2011, 166 (2) : 154 - 163.
  • 3Jadidi-Niaragh F, Ghslamfarsa G, Yousefi M, et al. Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions[J]. Tumour Biol, 2013, 34(4) : 2031 -2039.
  • 4D'Arena G, Simeon V, De Martino L, et al. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia [ J ]. Int J Immtmophthol Pharmacol, 2013, 26( 1 ) : 117 - 125.
  • 5D'Arena G, Rossi G, Vannata B, et al. Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases [ J/OA ]. Mediterr J Hematol Infect Dis, 2012, 4( 1 ) : e2012053.
  • 6Jadidi-Niaragh F, Yousefi M, Memarian A, et al. Increased frequency of CI)8 + and CIM+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression [ J]. Cancer Invest, 2013, 31 (2): 121-131.
  • 7Dasgupta A, Mahapatra M, Saxena R, et al. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3 [ J]. Leuk Lymphoma, 2013,54(4) : 778 -789.
  • 8Lad DP, Varma S, Varma N, et al. Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias[ J] . Leuk Lymphoma, 2013, 54 (5) : 1012 -1019.
  • 9Biancotto A, Dagur PK, Fuchs JC, et al. Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia [J]. Mod Pathol, 2012, 25(2) : 246 -259.
  • 10Weiss L, Melchardt T, Egle A, et al. Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia [J]. Cancer, 2011, 117(10) : 2163 -2169.

共引文献68

同被引文献65

  • 1刘美兰,陈家雪,陈俊良,丁洁芸,师调调,龚美玲,宋照风,赵海全.白术多糖对环磷酰胺诱导的南海麻黄鸡免疫抑制的调节作用[J].中国家禽,2022,44(5):55-62. 被引量:9
  • 2武燕.宫颈癌患者Th1/Th2细胞因子表达水平的研究[J].肿瘤研究与临床,2006,18(5):310-312. 被引量:24
  • 3李锋,熊丽丽,田晓予,米建强.高危型HPV感染的宫颈癌和癌前病变中Th1/Th2漂移情况研究[J].河南科技大学学报(医学版),2007,25(2):88-89. 被引量:7
  • 4张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2012:139-143.
  • 5Chiorarzi N, Rai KR,Ferrarini M, et al. Chronic lymphocytic leukemia[J].N Engl J Med,2005,352(8) :804-815.
  • 6Hojjat-Farsangi M, Jeddi-Tehrani M, Raravi SM, et al.Immu- noglobulin heavy chain variable region gene usage and muta- tional status of the leukemic B ceils in Iranian patients with chronic lymphocytic leukemia [J]. Cancer Sci, 2009,100 (12) : 2346-2353.
  • 7DrArena G, Simeon V ,Auria F, et al. Regulatory T-cells in chronic lymphocytic leukemia : actor or innocent bystander[J]. Am J Blood Res,2013,3(1) :52-57.
  • 8Dr Arena G, Rossi G, Vannata B, et ah Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseases[J]. Meditrr J Hematol Infect Dis,2012,4(1) :136-141.
  • 9Salluto F, Lanzavecchia A. Heterogeneity of CD4 + memory T cells: functional modules for tailored immunity [J]. Eur J Im- munol, 2009,39 (8) : 2076-2082.
  • 10Podhorecka M, Dmoszynska A, Rolinski J, et al. T type1/ type2 subsets balance in B-cell chronic lymphocytic leukemia- the three-color flow cytometry analysis[J]. Leuk Res, 2002, 26(7) :657-660.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部